Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Report 2017

Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Report 2017

1 High Performance Active Pharmaceutical Ingredients (HPAPI) Market Overview

1.1 Product Overview and Scope of High Performance Active Pharmaceutical Ingredients (HPAPI)

1.2 Classification of High Performance Active Pharmaceutical Ingredients (HPAPI) by Product Category

1.2.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Sales) Comparison by Type (2012-2022)

1.2.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Sales) Market Share by Type (Product Category) in 2016

1.2.3 Synthetic Ingredients

1.2.4 Biological Ingredients

1.2.5 Others

1.3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market by Application/End Users

1.3.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (Volume) and Market Share Comparison by Application (2012-2022)

1.3.2 Oncology

1.3.3 Glaucoma

1.3.4 Anti-diabetic

1.3.5 Cardiovascular

1.3.6 Musculoskeletal

1.3.7 Hormonal

1.3.8 Others

1.4 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market by Region

1.4.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Value) Comparison by Region (2012-2022)

1.4.2 United States High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2012-2022)

1.4.3 China High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2012-2022)

1.4.4 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2012-2022)

1.4.5 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2012-2022)

1.4.6 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2012-2022)

1.4.7 India High Performance Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2012-2022)

1.5 Global Market Size (Value and Volume) of High Performance Active Pharmaceutical Ingredients (HPAPI) (2012-2022)

1.5.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Growth Rate (2012-2022)

1.5.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate (2012-2022)

2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Competition by Players/Suppliers, Type and Application

2.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Competition by Players/Suppliers

2.1.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Market Share of Key Players/Suppliers (2012-2017)

2.1.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Share by Players/Suppliers (2012-2017)

2.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume and Value) by Type

2.2.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Market Share by Type (2012-2017)

2.2.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Market Share by Type (2012-2017)

2.3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume and Value) by Region

2.3.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Market Share by Region (2012-2017)

2.3.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Market Share by Region (2012-2017)

2.4 Global High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume) by Application

3 United States High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume, Value and Sales Price)

3.1 United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Value (2012-2017)

3.1.1 United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Growth Rate (2012-2017)

3.1.2 United States High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate (2012-2017)

3.1.3 United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price Trend (2012-2017)

3.2 United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Players

3.3 United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Type

3.4 United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Application

4 China High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume, Value and Sales Price)

4.1 China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Value (2012-2017)

4.1.1 China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Growth Rate (2012-2017)

4.1.2 China High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate (2012-2017)

4.1.3 China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price Trend (2012-2017)

4.2 China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Players

4.3 China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Type

4.4 China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Application

5 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume, Value and Sales Price)

5.1 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Value (2012-2017)

5.1.1 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Growth Rate (2012-2017)

5.1.2 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate (2012-2017)

5.1.3 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price Trend (2012-2017)

5.2 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Players

5.3 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Type

5.4 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Application

6 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume, Value and Sales Price)

6.1 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Value (2012-2017)

6.1.1 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Growth Rate (2012-2017)

6.1.2 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate (2012-2017)

6.1.3 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price Trend (2012-2017)

6.2 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Players

6.3 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Type

6.4 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Application

7 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume, Value and Sales Price)

7.1 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Value (2012-2017)

7.1.1 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Growth Rate (2012-2017)

7.1.2 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate (2012-2017)

7.1.3 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price Trend (2012-2017)

7.2 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Players

7.3 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Type

7.4 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Application

8 India High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume, Value and Sales Price)

8.1 India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Value (2012-2017)

8.1.1 India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Growth Rate (2012-2017)

8.1.2 India High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate (2012-2017)

8.1.3 India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price Trend (2012-2017)

8.2 India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Players

8.3 India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Type

8.4 India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Application

9 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Players/Suppliers Profiles and Sales Data

9.1 Bristol-Myers Squibb

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

9.1.2.1 Product A

9.1.2.2 Product B

9.1.3 Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

9.1.4 Main Business/Business Overview

9.2 Novartis

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

9.2.2.1 Product A

9.2.2.2 Product B

9.2.3 Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

9.2.4 Main Business/Business Overview

9.3 Sanofi Aventis

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

9.3.2.1 Product A

9.3.2.2 Product B

9.3.3 Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

9.3.4 Main Business/Business Overview

9.4 Pfizer

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

9.4.2.1 Product A

9.4.2.2 Product B

9.4.3 Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

9.4.4 Main Business/Business Overview

9.5 Lonza

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

9.5.2.1 Product A

9.5.2.2 Product B

9.5.3 Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

9.5.4 Main Business/Business Overview

9.6 Novasep

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

9.6.2.1 Product A

9.6.2.2 Product B

9.6.3 Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

9.6.4 Main Business/Business Overview

9.7 Hospira

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

9.7.2.1 Product A

9.7.2.2 Product B

9.7.3 Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

9.7.4 Main Business/Business Overview

9.8 BASF

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

9.8.2.1 Product A

9.8.2.2 Product B

9.8.3 BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

9.8.4 Main Business/Business Overview

9.9 Merck

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

9.9.2.1 Product A

9.9.2.2 Product B

9.9.3 Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

9.9.4 Main Business/Business Overview

9.10 Bayer

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

9.10.2.1 Product A

9.10.2.2 Product B

9.10.3 Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

9.10.4 Main Business/Business Overview

9.11 Teva Pharmaceuticals

9.12 Boehringer Ingelheim

10 High Performance Active Pharmaceutical Ingredients (HPAPI) Maufacturing Cost Analysis

10.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI)

10.3 Manufacturing Process Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI)

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of High Performance Active Pharmaceutical Ingredients (HPAPI) Major Manufacturers in 2016

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Forecast (2017-2022)

14.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume, Revenue and Price Forecast (2017-2022)

14.1.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Growth Rate Forecast (2017-2022)

14.1.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate Forecast (2017-2022)

14.1.3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Price and Trend Forecast (2017-2022)

14.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)

14.2.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Growth Rate Forecast by Regions (2017-2022)

14.2.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate Forecast by Regions (2017-2022)

14.2.3 United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.4 China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.5 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.6 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.7 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.8 India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume, Revenue and Price Forecast by Type (2017-2022)

14.3.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Forecast by Type (2017-2022)

14.3.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Forecast by Type (2017-2022)

14.3.3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Price Forecast by Type (2017-2022)

14.4 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology/Research Approach

16.1.1 Research Programs/Design

16.1.2 Market Size Estimation

16.1.3 Market Breakdown and Data Triangulation

16.2 Data Source

16.2.1 Secondary Sources

16.2.2 Primary Sources

16.3 Disclaimer

Figure Product Picture of High Performance Active Pharmaceutical Ingredients (HPAPI)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Comparison (K MT) by Type (2012-2022)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type (Product Category) in 2016

Figure Synthetic Ingredients Product Picture

Figure Biological Ingredients Product Picture

Figure Others Product Picture

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Comparison (K MT) by Application (2012-2022)

Figure Global Sales Market Share of High Performance Active Pharmaceutical Ingredients (HPAPI) by Application in 2016

Figure Oncology Examples

Figure Glaucoma Examples

Figure Anti-diabetic Examples

Figure Cardiovascular Examples

Figure Musculoskeletal Examples

Figure Hormonal Examples

Figure Others Examples

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Million USD) by Regions (2012-2022)

Figure United States High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) and Growth Rate (2012-2022)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Market Major Players High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) (2012-2017)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) of Key Players/Suppliers (2012-2017)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Share by Players/Suppliers (2012-2017)

Figure 2016 High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Share by Players/Suppliers

Figure 2017 High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Share by Players/Suppliers

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) by Players/Suppliers (2012-2017)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) by Players/Suppliers (2012-2017)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Players/Suppliers (2012-2017)

Table 2016 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Players

Table 2017 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Players

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Market Share by Type (2012-2017)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Share (K MT) by Type (2012-2017)

Figure Sales Market Share of High Performance Active Pharmaceutical Ingredients (HPAPI) by Type (2012-2017)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate by Type (2012-2017)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Market Share by Type (2012-2017)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Type (2012-2017)

Figure Revenue Market Share of High Performance Active Pharmaceutical Ingredients (HPAPI) by Type (2012-2017)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate by Type (2012-2017)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) and Market Share by Region (2012-2017)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Share by Region (2012-2017)

Figure Sales Market Share of High Performance Active Pharmaceutical Ingredients (HPAPI) by Region (2012-2017)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate by Region in 2016

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Market Share by Region (2012-2017)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Share (%) by Region (2012-2017)

Figure Revenue Market Share of High Performance Active Pharmaceutical Ingredients (HPAPI) by Region (2012-2017)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate by Region in 2016

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Market Share by Region (2012-2017)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Share (%) by Region (2012-2017)

Figure Revenue Market Share of High Performance Active Pharmaceutical Ingredients (HPAPI) by Region (2012-2017)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Region in 2016

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) and Market Share by Application (2012-2017)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Share (%) by Application (2012-2017)

Figure Sales Market Share of High Performance Active Pharmaceutical Ingredients (HPAPI) by Application (2012-2017)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Application (2012-2017)

Figure United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure United States High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2017)

Figure United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price (USD/MT) Trend (2012-2017)

Table United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Players (2012-2017)

Table United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Players (2012-2017)

Figure United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Players in 2016

Table United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Type (2012-2017)

Table United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type (2012-2017)

Figure United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type in 2016

Table United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Application (2012-2017)

Table United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application (2012-2017)

Figure United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application in 2016

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2017)

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price (USD/MT) Trend (2012-2017)

Table China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Players (2012-2017)

Table China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Players (2012-2017)

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Players in 2016

Table China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Type (2012-2017)

Table China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type (2012-2017)

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type in 2016

Table China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Application (2012-2017)

Table China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application (2012-2017)

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application in 2016

Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2017)

Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price (USD/MT) Trend (2012-2017)

Table Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Players (2012-2017)

Table Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Players (2012-2017)

Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Players in 2016

Table Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Type (2012-2017)

Table Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type (2012-2017)

Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type in 2016

Table Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Application (2012-2017)

Table Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application (2012-2017)

Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application in 2016

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2017)

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price (USD/MT) Trend (2012-2017)

Table Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Players (2012-2017)

Table Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Players (2012-2017)

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Players in 2016

Table Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Type (2012-2017)

Table Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type (2012-2017)

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type in 2016

Table Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Application (2012-2017)

Table Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application (2012-2017)

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application in 2016

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2017)

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price (USD/MT) Trend (2012-2017)

Table Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Players (2012-2017)

Table Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Players (2012-2017)

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Players in 2016

Table Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Type (2012-2017)

Table Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type (2012-2017)

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type in 2016

Table Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Application (2012-2017)

Table Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application (2012-2017)

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application in 2016

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2017)

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price (USD/MT) Trend (2012-2017)

Table India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Players (2012-2017)

Table India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Players (2012-2017)

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Players in 2016

Table India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Type (2012-2017)

Table India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type (2012-2017)

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type in 2016

Table India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Application (2012-2017)

Table India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application (2012-2017)

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application in 2016

Table Bristol-Myers Squibb Basic Information List

Table Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)

Figure Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Global Market Share (2012-2017

Figure Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Global Market Share (2012-2017)

Table Novartis Basic Information List

Table Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)

Figure Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Global Market Share (2012-2017

Figure Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Global Market Share (2012-2017)

Table Sanofi Aventis Basic Information List

Table Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)

Figure Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Global Market Share (2012-2017

Figure Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Global Market Share (2012-2017)

Table Pfizer Basic Information List

Table Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)

Figure Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Global Market Share (2012-2017

Figure Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Global Market Share (2012-2017)

Table Lonza Basic Information List

Table Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)

Figure Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Global Market Share (2012-2017

Figure Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Global Market Share (2012-2017)

Table Novasep Basic Information List

Table Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)

Figure Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Global Market Share (2012-2017

Figure Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Global Market Share (2012-2017)

Table Hospira Basic Information List

Table Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)

Figure Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Global Market Share (2012-2017

Figure Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Global Market Share (2012-2017)

Table BASF Basic Information List

Table BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)

Figure BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Global Market Share (2012-2017

Figure BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Global Market Share (2012-2017)

Table Merck Basic Information List

Table Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)

Figure Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Global Market Share (2012-2017

Figure Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Global Market Share (2012-2017)

Table Bayer Basic Information List

Table Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)

Figure Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Global Market Share (2012-2017

Figure Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Global Market Share (2012-2017)

Table Teva Pharmaceuticals Basic Information List

Table Boehringer Ingelheim Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of High Performance Active Pharmaceutical Ingredients (HPAPI)

Figure Manufacturing Process Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI)

Figure High Performance Active Pharmaceutical Ingredients (HPAPI) Industrial Chain Analysis

Table Raw Materials Sources of High Performance Active Pharmaceutical Ingredients (HPAPI) Major Players in 2016

Table Major Buyers of High Performance Active Pharmaceutical Ingredients (HPAPI)

Table Distributors/Traders List

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Price (USD/MT) and Trend Forecast (2017-2022)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) Forecast by Regions (2017-2022)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share Forecast by Regions (2017-2022)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share Forecast by Regions in 2022

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) Forecast by Regions (2017-2022)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share Forecast by Regions (2017-2022)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share Forecast by Regions in 2022

Figure United States High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure United States High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate Forecast (2017-2022)

Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) Forecast by Type (2017-2022)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share Forecast by Type (2017-2022)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) Forecast by Type (2017-2022)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share Forecast by Type (2017-2022)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Price (USD/MT) Forecast by Type (2017-2022)

Table Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) Forecast by Application (2017-2022)

Figure Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources